Works from 2020
Real world observational study using Clonoseq® next generation sequencing in hematologic malignancies: The 'Watch' Registry, Krish Patel, Neil Bailey, Michael A. Thompson, et al. (Abstract)
Utilization of COVID-19 treatments and clinical outcomes among patients with cancer: A COVID-19 and Cancer Consortium (CCC19) cohort study, Donna R Rivera, Solange Peters, Orestis A Panagiotou, et al. (Article)
Waging war on war metaphors in cancer and COVID-19, Jonathan M Marron, Don S Dizon, Banu Symington, et al. (Article)
Association of circulating tumor DNA and circulating tumor cells after neoadjuvant chemotherapy with disease recurrence in patients with triple-negative breast cancer: Preplanned secondary analysis of the BRE12-158 randomized clinical trial, Milan Radovich, Guanglong Jiang, Bradley A Hancock, et al. (Article)
LBA72 Assessment of clinical and laboratory prognostic factors in patients with cancer and SARS-CoV-2 infection: The COVID-19 and Cancer Consortium (CCC19), P Grivas, J Warner, Michael A. Thompson, et al. (Abstract)
Systemic cancer treatment-related outcomes in patients with SARS-CoV-2 infection: A CCC19 registry analysis, T M. Wise-Draper, A Desai, Michael A. Thompson, et al. (Article)
Caplacizumab for treatment of thrombotic thrombocytopenic purpura in a patient with anaphylaxis to fresh-frozen plasma, Mehraboon S. Irani, Federico Sanchez, and Kenneth Friedman (Article)
Phase II trial of carfilzomib plus irinotecan in patients with small-cell lung cancer who have progressed on prior platinum-based chemotherapy, Susanne M Arnold, Kari Chansky, Maria Q Baggstrom, et al. (Article)
Diagnostic and molecular testing patterns in patients with newly diagnosed acute myeloid leukemia in the Connect® MDS/AML Disease Registry, Daniel A. Pollyea, Tracy I. George, Michael A. Thompson, et al. (Article)
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study, Nicole M Kuderer, Toni K Choueiri, Dimpy P Shah, et al. (Article)
Clinical impact of COVID-19 on patients with cancer: Data from the COVID-19 and Cancer Consortium (CCC19), Jeremy L Warner, Sam Rubinstein, and Michael A. Thompson (Abstract)
HealthTree Patient Portal mediated myeloma patient-reported vaccination and antibiotic use, Michael A. Thompson, Jenny Ahlstrom, and Nathan W. Sweeney (Abstract)
Molecular alterations with hyperprogression in lung cancer patients treated with immune checkpoint inhibitors in a large health system, Eyob Tadesse, Kayla Heslin, Mohamed Hendawi, et al. (Abstract)
Multiple myeloma (MM) vaccination (influenza, FV and pneumococcal, PV) rates worldwide and impact on infection, hospitalization, and death, Michael A. Thompson, Caitlin Costello, and et al (Abstract)
Reduced blood product utilization via implementation of an anemia clinic and consult service in a large health system hospital, Reid Christian Bowers, Michael A. Thompson, Sandra Tomany Korman, et al. (Abstract)
Concordant genomic vulnerabilities of patient-derived cell line and matched xenograft-derived cell line through whole exome sequencing in breast-brain metastatic cancer, Jun Yin, Aspen T. Duffin, Kate Dennert, et al. (Article)
Impact on patient outcomes of creating a robotic complex pancreatic surgery training program, Nicholas Sich, Geoffrey Bellini, James Weese, et al. (Poster)
Oncologic outcomes of robotic compared to open pancreatic surgery: A National Cancer Database participant user file study, Geoffrey Bellini, Maharaj Singh, James Weese, et al. (Poster)
Oncology precision medicine for hepatobiliary and pancreatic cancer: Insights and updates from a large community health system, Geoffrey Bellini, Nicholas Sich, Jennifer Godden, et al. (Poster)
Transplant referral patterns for patients (pts) with newly diagnosed (ND) higher-risk (HR) myelodysplastic dyndromes (MDS), and European leukemianet (ELN) 2010 intermediate-tisk (IR) or adverse-risk (AR) acute myeloid leukemia (AML) in the Connect® MDS/AML registry, Benjamin Tomlinson, Marcos de Lima, Christopher R. Cogle, et al. (Abstract)
Comparing survival outcomes for neoadjuvant therapy versus adjuvant therapy in the management of stage 1 pancreatic adenocarcinoma: A National Cancer Database study, Samit K. Datta, Geoffrey Bellini, Maharaj Singh, et al. (Abstract)
Oncology precision medicine for hepatobiliary and pancreatic cancer: Insights and updates upon an institutional review, Geoffrey Bellini, Nicholas Sich, Jennifer Godden, et al. (Abstract)
Comprehensive genomic profiling of 30,000 consecutive solid tumors, Michael Thompson (Article)
Crowdsourcing a crisis response for COVID-19 in oncology, Aakash Desai, Jeremy Warner, Nicole Kuderer, et al. (Article)
Works from 2019
546 Tumor free resection margin better with surgical resection as opposed to endoscopic resection for esophageal T1b adenocarcinoma, Samit K. Datta, Geoffrey Bellini, Maharaj Singh, et al. (Abstract)
Oncology precision medicine for hepatobiliary and pancreatic cancer: An institutional review, Geoffrey Bellini, Jennifer Godden, James Weese, et al. (Abstract)
Physiological and psychosocial effects of a highly structured exercise program on breast cancer survivorship, Judy A. Tjoe, Linda B Piacentine, Jun Yin, et al. (Abstract)
Use of treatment pathways reduce cost and decrease ED utilization and unplanned hospital admissions in patients (pts) with stage II breast cancer, James Weese, Corey J. Shamah, Federico A. Sanchez, et al. (Abstract)
p16 as a biomarker to distinguish atypical ductal hyperplasia from ductal carcinoma in situ and to predict breast cancer progression, Judy A. Tjoe, Brittany S. Last, and Jun Yin (Abstract)
Mo1412 – Oncologic outcomes of robotic compared to open pancreatic surgery: A national cancer database participant user file study, Geoffrey Bellini, Maharaj Singh, James Weese, et al. (Abstract)
Determining value of a precision medicine program in a vertically integrated healthcare system, James Weese, Michael A. Thompson, and Jennifer Godden (Oral/Podium Presentation)
Coordinating an Oncology Precision Medicine Clinic Within an Integrated Health System: Lessons Learned in Year One, Michael A. Thompson, Jennifer J. Godden, Deborah Wham, Antony Ruggeri, Michael P. Mullane, Amanda Wilson, Shamsuddin Virani, Scott M. Weissman, Brenda Ramczyk, Pamela Vanderwall, and James L. Weese (Review)